Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity.
暂无分享，去创建一个
E. Campo | D. Colomer | P. Lichter | M. Iskar | K. Rippe | M. Feuerer | Norman L Mack | S. Stilgenbauer | S. Dietrich | M. Zapatka | Manfred Schmidt | R. Gabriel | S. Öztürk | V. Kalter | M. Seiffert | A. Ramsay | L. Klett | N. Ioannou | Bola S Hanna | J. Bloehdorn | Yashna Paul | P. Roessner | Laura Llaó-Cid | B. Hanna | John K. L. Wong | Lara C. Klett | M. Schmidt | Richard Gabriel | Verena Kalter